|
|
Docu-menta >
Buscar por Autor Fañanas-Baquero, S
Mostrando resultados 1 a 5 de 5
| Fecha de publicación | Título | Autor(es) | | may-2021 | Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency | Fañanas-Baquero, S; Quintana-Bustamante, O; Dever, DP; Alberquilla, O; Sanchez-Dominguez, R; Camarena, J; Ojeda-Perez, I; Dessy-Rodriguez, M; Turk, R; Schubert, MS; Lattanzi, A; Xu, L; Lopez-Lorenzo, JL; Bianchi, P; Bueren, JA; Behlke, MA; Porteus, M; Segovia, JC |
| mar-2022 | Gene Editing for Inherited Red Blood Cell Diseases | Quintana-Bustamante, O; Fañanas-Baquero, S; Dessy-Rodríguez, M; Ojeda-Pérez, I; Segovia, JC |
| 16-oct-2019 | Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA | Quintana-Bustamante, O; Fañanas-Baquero, S; Orman, I; Torres, R; Duchateau, P; Poirot, L; Gouble, A; Bueren, JA; Segovia, JC |
| 1-jun-2021 | Natural estrogens enhance the engraftment of human hematopoietic stem and progenitor cells in immunodeficient mice | Fañanas-Baquero, S; Orman, I; Becerra Aparicio, F; Bermudez de Miguel, S; Garcia Merino, J; Yañez, R; Fernandez Sainz, Y; Sánchez, R; Dessy-Rodrígue, M; Alberquilla, O; Alfaro, D; Zapata, A; Bueren, JA; Segovia, JC; Quintana-Bustamante, O |
| jul-2021 | Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment | Navarro, S; Quintana-Bustamante, O; Sanchez-Dominguez, R; Lopez-Manzaneda, S; Ojeda-Perez, I; Garcia-Torralba, A; Alberquilla, O; Law, K; Beard, BC; Bastone, A; Rothe, M; Villanueva, M; Ramirez, JC; Fañanas-Baquero, S; Nieto-Romero, V; Gutierrez, S; Nicoletti, E; García-Bravo, M; Bueren, JA; Schwartz, JD; Segovia, JC |
Mostrando resultados 1 a 5 de 5
|
